They ultimately amplify by expanding the number of differentiated & mature cells.They can differentiate to make multiple types of cells. They can self-renew and make two new stem cell.Stem cells are unspecialized cells that have not yet “decided” what type of adult cell they will be.This unique experience is a part of the Summer Undergraduate Research Fellowship (SURF), which supports motivated University of Wisconsin–Madison undergraduate students as they pursue research in the stem cell sciences.Can doctors use stem cells to treat patients? The Stem Cell and Regenerative Medicine Center labs welcomed new members this summer, as five talented undergraduate students joined mentors for more than 10-weeks of collaborative research. OctoSURF program prepares students to ride the waves of research Both are also Waisman Center investigators and Stem Cell and Regenerative Medicine members. Department of Defense (DOD) grant, will be led by Xinyu Zhao professor of neuroscience, and Anita Bhattacharyya, assistant professor of cell and regenerative biology. The study, which will be supported by a three-million-dollar U.S. OctoNew Department of Defense Grant to Study Fragile X Syndrome in Human CellsĪ new study will characterize human stem cell models of fragile X syndrome (FXS) to better understand the mechanisms behind FXS symptoms and how those may inform the search for effective therapies. Researchers at the University of Wisconsin–Madison are developing the means to turn stem cells into a wide range of specific types of spinal cord neurons and cells in the hindbrain - the critical nexus between the spinal cord and the brain - paving the way for improved prevention and treatment of spinal cord disease. JanuImproved understanding of early spinal cord development paves the way for new treatments This is an important development, which indicates that these organoids can replace diseased cells and carry sensory information to the brain. While these organoids were developed nearly a decade ago, this is the first time that Gamm and his lab have shown that the organoids have the capacity to communicate across synapses, tiny gaps between cells. The organized clusters of cells, or organoids, used in the study were developed in the lab of David Gamm, a SCRMC member, UW–Madison ophthalmology professor, and director of the McPherson Eye Research Institute. Now, researchers at the University of Wisconsin–Madison have developed a way to move therapies across the brain’s protective membrane to deliver brain-wide therapy with a range of biological medications and treatments.įebruLab-grown retinal eye cells make successful connections, open door for clinical trials to treat blindnessĪ new study suggests that retinal cells grown from stem cells may be ready for trials in humans with degenerative eye disorders. Gene therapies have the potential to treat neurological disorders like Alzheimer’s and Parkinson’s diseases, but they face a common barrier - the blood-brain barrier. MaNew nanocapsules deliver therapy brain-wide, edit Alzheimer’s gene in mice New research from the University of Wisconsin–Madison is helping to change that by identifying the cell population that causes GVHD, a target that may make bone marrow transplants safer and more effective. This honor recognizes new and on-going research of the highest quality and significance.ĪpSCRMC researchers identify cell type that could be key to preventing marrow transplant complication Stem Cell & Regenerative Medicine members Feyza Engin and Ahmed Mahmoud have received the 2023-2024 University of Wisconsin-Madison Vilas Associates Award. Additionally, this program will foster interdisciplinary collaborations among campus investigators.ĪpTwo SCRMC members receive the 2023-2024 Vilas Associates Award We invite you to meet the winners of the 2023 SCRMC Research Training Awards Program, which provides unique, interdisciplinary training for four future leaders in stem cell and regenerative medicine research. These talented undergraduate students will be paired with mentors for more than 10-weeks of collaborative research.Ģ023 SCRMC Research Training Award Winners Announced Stem Cell and Regenerative Medicine Director, Tim Kamp and a team of collaborators will receive one of sixteen Research Forward grants to study new avenues to treat heart failure using an engineered enzyme and human pluripotent stem cells.Ĭongratulations to the Summer Undergraduate Research Fellowship (SURF) Award Winners! Center Update SCRMC director and collaborators receive Research Forward Award
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |